Warner Chilcott (WCRX)

19.60 +0.39  +2.03%  May 20, 4:58PM
Add to Watchlists Create an Alert

Warner Chilcott SG&A Expense Quarterly:

191.00M for Dec. 31, 2012
View Full Chart

Warner Chilcott SG&A Expense Quarterly Chart

    Warner Chilcott Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 191.00M
    Sept. 30, 2012 183.00M
    June 30, 2012 173.00M
    March 31, 2012 198.00M
    Dec. 31, 2011 207.00M
    Sept. 30, 2011 216.00M
    June 30, 2011 248.00M
    March 31, 2011 253.00M
    Dec. 31, 2010 238.05M
    Sept. 30, 2010 251.44M
    June 30, 2010 280.80M
    March 31, 2010 320.06M
    Dec. 31, 2009 277.48M
    Sept. 30, 2009 59.12M
    June 30, 2009 53.02M
       
    March 31, 2009 46.77M
    Dec. 31, 2008 44.40M
    Sept. 30, 2008 45.92M
    June 30, 2008 47.10M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    WCRX SG&A Expense Quarterly Benchmarks

    Companies
    Actavis 413.00M
    Mylan 351.37M
    Valeant Pharmaceuticals International 246.35M

    WCRX SG&A Expense Quarterly Rankings

    Overall 91st percentile
    678 of 8002
    Sector 89th percentile
    71 of 650 in Healthcare
    Industry 87th percentile
    8 of 65 in Drug Manufacturers - Specialty & Generic

    WCRX SG&A Expense Quarterly Range, Past 5 Years

    Minimum 44.40M Dec 2008
    Maximum 320.06M Mar 2010
    Average 175.43M